Ekso Bionics Holdings Inc. (EKSO)

Name: Ekso Bionics Holdings Inc. (EKSO) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Ekso Bionics Holdings Inc. (EKSO)

Stock Card

$11.80

$0.00 (0.00%)

As on 15-May-2026 16:00EDT

Market cap

$42 Mln

Revenue (TTM)

$12 Mln

P/E Ratio

P/B Ratio

19.9

Div. Yield

0 %

Ekso Bionics Holdings (EKSO) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 11.65 High: 11.65

52 Week Range

Low: 0.27 High: 13.50

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.1 %
ROCE

-- %
Industry P/E

46.09
EV/EBITDA

0.5
Debt to Equity

0.1
Book Value

$--
EPS

$-5.3
Face value

--
Shares outstanding

3,563,381

10 Years Aggregate

CFO

$-174.09 Mln

EBITDA

$-200.61 Mln

Net Profit

$-199.83 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Ekso Bionics Holdings (EKSO)	36.6	18.0	19.6	74.0	-20.4	-31.4	-38.7
BSE Sensex^*	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 15-May-2026 | *As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Ekso Bionics Holdings (EKSO)	-5.6	-75.3	110.1	-55.1	-56.8	4.5	-68.5
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Ekso Bionics Holdings (EKSO)

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton;... Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California. Read more

CEO & Director

Mr. Scott G. Davis
CEO & Director

Mr. Scott G. Davis
Headquarters

San Rafael, CA
Website

https://www.eksobionics.com

FAQs for Ekso Bionics Holdings (EKSO)

What is the current share price of Ekso Bionics Holdings Inc (EKSO) Today?

The share price of Ekso Bionics Holdings Inc (EKSO) is $11.80 (NASDAQ) as of 15-May-2026 16:00 EDT. Ekso Bionics Holdings Inc (EKSO) has given a return of -20.4% in the last 3 years.

What is the current PB & PE ratio of Ekso Bionics Holdings Inc (EKSO)?

Since, TTM earnings of Ekso Bionics Holdings Inc (EKSO) is negative, P/E ratio is not available.
The P/B ratio of Ekso Bionics Holdings Inc (EKSO) is 19.86 times as on 15-May-2026, a 424 premium to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-2.20	2.85
2024	-0.09	0.08
2023	-0.16	0.19
2022	-0.07	0.04
2021	-0.23	0.06

What is the 52 Week High and Low of Ekso Bionics Holdings Inc (EKSO)?

The 52-week high and low of Ekso Bionics Holdings Inc (EKSO) are Rs 13.50 and Rs 0.27 as of 06-Sep-2026.

What is the market cap of Ekso Bionics Holdings Inc (EKSO)?

Ekso Bionics Holdings Inc (EKSO) has a market capitalisation of $ 42 Mln as on 15-May-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Ekso Bionics Holdings Inc (EKSO)?

Before investing in Ekso Bionics Holdings Inc (EKSO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.